Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEO-MINDSET: P2Y12 Monotherapy vs DAPT in ACS
NCT04360720Phase 3Completed
- Sponsor
- Hospital Israelita Albert Einstein
- Start
- Oct 2020
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor, prasugrel in acute coronary syndrome (ACS), sponsored by Hospital Israelita Albert Einstein. Started Oct 2020; status: completed.
02
Drugs
ticagrelorprasugrel
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04360720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04360720.